Literature DB >> 33443551

2020 as the Year of Quarantine Myopia.

Caroline C W Klaver1,2,3,4, Jan Roelof Polling2,5, Clair A Enthoven1,2,6.   

Abstract

Entities:  

Year:  2021        PMID： 33443551     DOI： 10.1001/jamaophthalmol.2020.6231

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN： 2168-6165            Impact factor:   7.389


× No keyword cloud information.
  6 in total

1.  Effect of COVID-19 lockdown on refractive errors in Italian children aged 5-12 years: A multi-center retrospective study.

Authors:  Edoardo Trovato Battagliola; Pietro Mangiantini; Mattia D'Andrea; Mariaelena Malvasi; Lorenzo Loffredo; Sergio Zaccaria Scalinci; Anna Maria Comberiati; Raffaele Migliorini; Elena Pacella
Journal:  Eur J Ophthalmol       Date:  2022-06-09       Impact factor: 1.922

2.  Commentary: Behavioral changes in school-going children during the COVID-19 pandemic.

Authors:  Savleen Kaur; Jaspreet Sukhija
Journal:  Indian J Ophthalmol       Date:  2021-12       Impact factor: 1.848

3.  Complex Interplay Between COVID-19 Lockdown and Myopic Progression.

Authors:  Tao Cai; Lianghui Zhao; Ling Kong; Xianli Du
Journal:  Front Med (Lausanne)       Date:  2022-03-21

4.  Pediatric Myopia Progression During the COVID-19 Pandemic Home Quarantine and the Risk Factors: A Systematic Review and Meta-Analysis.

Authors:  Ze Yang; Xiang Wang; Shiyi Zhang; Haiyong Ye; Yuanqing Chen; Yongliang Xia
Journal:  Front Public Health       Date:  2022-07-22

5.  Outbreak of COVID-19-Related Myopia Progression in Adults: A Preliminary Study.

Authors:  Thitika Kohmarn; Noppadol Srisurattanamethakul; Akarapon Watcharapalakorn; Teera Poyomtip; Chotika Poolsanam
Journal:  Clin Optom (Auckl)       Date:  2022-08-04

6.  Impact of COVID-19 Home Confinement in Children's Refractive Errors.

Authors:  Cristina Alvarez-Peregrina; Clara Martinez-Perez; Cesar Villa-Collar; Cristina Andreu-Vázquez; Alicia Ruiz-Pomeda; Miguel Ángel Sánchez-Tena
Journal:  Int J Environ Res Public Health       Date:  2021-05-17       Impact factor: 3.390
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.